H And H

H And H, a pharmaceutical preparation manufacturer headquartered in Hong Kong, reported a total of approximately 392,939,000 kg CO2e in 2024. This figure comprises approximately 2,543,000 kg CO2e from Scope 1 emissions and approximately 9,911,000 kg CO2e from Scope 2 emissions (location-based). Scope 3 emissions accounted for the vast majority, at approximately 390,396,000 kg CO2e, with purchased goods and services being the largest contributor within this scope, amounting to approximately 321,187,000 kg CO2e.

In 2023, H And H's total emissions were approximately 408,557,000 kg CO2e. This included approximately 2,721,000 kg CO2e in Scope 1 emissions and approximately 9,384,000 kg CO2e in Scope 2 emissions (location-based). Scope 3 emissions were approximately 405,836,000 kg CO2e, with purchased goods and services representing approximately 341,016,000 kg CO2e of this total.

H And H has established several climate commitments. The company aims to achieve net-zero emissions by 2030, with near-zero targets for Scope 1 and Scope 2 emissions by the middle of the decade. Furthermore, H And H has committed to a Science Based Targets initiative (SBTi) target to reduce absolute Scope 1 GHG emissions by 46.2% by 2031 from a 2022 base year. They also commit to sourcing 100% renewable